Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2.
Biomedicines
; 11(1)2023 Jan 08.
Article
de En
| MEDLINE
| ID: mdl-36672668
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Biomedicines
Année:
2023
Type de document:
Article
Pays d'affiliation:
Allemagne